MicroRNAs and Cytokines in Peri-Implantitis Tissue
NCT05765942 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45
Last updated 2023-03-17
Summary
Peri-implantitis is a non-linear and accelerating pattern of loss of supporting bone tissue associated with clinical signs of inflammation and increased probing depths compared to baseline measurements. It can present as an asymptomatic condition with infection and fast progression of bone resorption or clinically symptomatic with mucosal inflammation, redness, edema, mucosal enlargement, bleeding on probing (BOP), suppuration, increased probing depth, and radiographic bone loss. The host immune defense against bacterial challenge is responsible for the damage, and the local immune-inflammatory process is associated with disrupted bone remodeling. New studies looking for predictive and accurate early biomarkers for this pathology have the utmost relevance. David Baltimore et al. proposed a feedback loop involving miRNA-146a and TLR signaling, which has been shown to be up-regulated in inflammatory diseases such as osteoarthritis and rheumatoid arthritis.
miRNA-146a and miRNA-155 were the first miRNAs identified to be induced in immune cells stimulated by TLRs and proinflammatory cytokines. Precision medicine uses molecular research and different biomarkers, population studies, and big data analysis to recreate complex disease models. Several studies have compared the miRNA profiles of patients with periodontitis with healthy patients. Although periodontitis and peri-implantitis share many features, researchers' findings of periodontitis are not necessarily applicable to peri-implantitis. In fact, based on emerging evidence, peri-implantitis, and periodontitis exhibit several key differences, including their histopathological and molecular characteristics. Considering the aforementioned analysis, inflammatory miRNAs may be differentially expressed in peri-implantitis tissue compared with healthy gingival tissue. This study will investigate the gene expression levels of miRNA-146a and miRNA-155 and their correlation with inflammatory levels of their target genes in human gingival tissue surrounding dental implants diagnosed with peri-implantitis and health.
Conditions
- Peri-implantitis
Sponsors & Collaborators
-
University of Baghdad
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-01
- Primary Completion
- 2023-06-01
- Completion
- 2023-12-01
Countries
- Iraq
Study Locations
More Related Trials
-
The Effect of Platelet Rich Fibrin Layers on Peri-implant Tissue Phenotype
NCT07033351 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Two Mini-Implant Lengths in the Infra-Zygomatic Crest Region
NCT06293872 ·Status: COMPLETED ·Phase: NA
-
Peri-Implantitis Surgical Treatment an RCT Study
NCT02575274 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Compliance and Cumulative Interceptive Rate After Therapy of Peri-implantitis
NCT05772078 ·Status: COMPLETED
-
Longitudinal Evaluation of Regenerative Treatment of Peri-implantitis Assited by Er,Cr:YSGG Laser: up to 10 Years Follow-up
NCT07104760 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical and Biochemical Evaluation of the Efficacy of Non-Surgical Treatment Approaches in the Treatment of Peri-implantitis
NCT05201443 ·Status: UNKNOWN ·Phase: NA
-
Surgical and Non-surgical Treatment of Peri-implantitis
NCT02241577 ·Status: COMPLETED ·Phase: NA
-
Peri-implantitis Between Periodontitis and Nonperiodontitis Sites With ARP
NCT05713682 ·Status: COMPLETED
-
Clinical, Prospective, Non-profit, Non-pharmacological Study on Geass Healing Abutment: Microbiological, Histological, and Immuno-histochemical Evaluation.
NCT05754970 ·Status: COMPLETED ·Phase: NA
-
Clinical Outcomes of Resective Surgical Treatment of Peri-Implantitis With or Without Implantoplasty
NCT04259840 ·Status: TERMINATED
-
Treatment of Peri-Implant Mucositis With Standard of Care and Bioptron Hyperlight Therapy
NCT05307445 ·Status: COMPLETED ·Phase: NA
-
Predictive Value of Reduced Keratinized Mucosa on the Secondary Prevention of Peri-implant Mucositis and Periimplantitis in Patients Attending Regular Supportive Peri-implant Care. A Longitudinal Analysis
NCT05804760 ·Status: COMPLETED
-
Surgical Treatment of Periimplantitis in Patients With Risk Factors
NCT03814434 ·Status: UNKNOWN ·Phase: NA
-
Monitoring of Implant Diseases: Diagnosis and Monitoring with AMMP-8 Test Technology
NCT06761521 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Treatment of Peri-implant Mucositis on Incongruous Dental Prostheses Versus Congruous
NCT05923554 ·Status: UNKNOWN ·Phase: NA
-
The Influence of Implant Position on the Occurrence of Biological Complications
NCT05358782 ·Status: UNKNOWN
-
Mechanical Treatment Peri-Implant Mucositis
NCT05664425 ·Status: COMPLETED ·Phase: NA
-
Characterizing the Inflammation Around Dental Implants: Bacterial Infection, Hypersensitivity or Both?
NCT06515886 ·Status: RECRUITING
-
Peri-implant Mucosal Changes Over Time Following Implant Provisional Removal in the Esthetic Zone
NCT06783595 ·Status: RECRUITING
-
Impact of Buccal Bone Thickness on Pathological Peri-implant Bone Loss: A 3-year Prospective Cohort Study
NCT02939222 ·Status: WITHDRAWN ·Phase: NA
-
Patients' Illness Perception of Peri-implant Diseases. A Cross-sectional Study
NCT06383351 ·Status: COMPLETED
-
Outcome After Dental Implant Treatment
NCT02671812 ·Status: COMPLETED
-
Dental Hygiene and Peri-Implant Tissues Homeostasis Ancillary Study
NCT03917264 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Inflammatory Mediators Surrounding Titanium or Zirconium Implant Abutments
NCT01870349 ·Status: COMPLETED
-
Influence of Timing of Implant Placement on Early Healing Molecular Events
NCT06276335 ·Status: RECRUITING ·Phase: NA